Core Insights - Sportsman's Warehouse reported a 2% increase in net sales to $249.1 million for the first quarter of fiscal year 2025, compared to $244.2 million in the same period last year, marking a significant recovery from a -13.5% decline in the previous year [1][7] - The company reaffirmed its full-year guidance for fiscal year 2025, expecting net sales to range from a decline of 1.0% to an increase of 3.5% and adjusted EBITDA between $33 million and $45 million [8] Financial Performance - Gross profit for the quarter was $75.6 million, representing 30.4% of net sales, an increase from 30.2% in the prior year, driven by improved inventory productivity and product margin rates in the fishing category [7] - Selling, general, and administrative (SG&A) expenses were $95.3 million, or 38.2% of net sales, down from 38.6% in the previous year, reflecting effective expense management [7] - The net loss for the quarter was $(21.3) million, compared to a net loss of $(18.1) million in the same quarter last year, while the adjusted net loss improved to $(15.6) million from $(17.8) million [7][22] Strategic Initiatives - The company is focusing on improving inventory precision, leveraging local expertise, and executing a digital-first marketing strategy to enhance customer loyalty and trust [3][6] - Anticipating increased tariffs, Sportsman's Warehouse made targeted inventory investments to secure critical products ahead of seasonal demand, balancing near-term gross margin pressure with inventory readiness [6] Outlook - The company plans to open one new store in Surprise, Arizona during fiscal year 2025 and is committed to generating positive free cash flow while paying down debt [8] - Total liquidity at the end of the first quarter was $122.1 million, consisting of $118.5 million available on credit facilities and $3.6 million in cash [7]

Based on market research, inguinal hernia repair is the most common type of hernia repairMALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. This milestone follows the ...

Core Viewpoint - Xcel Brands, Inc. is set to report its first quarter 2025 financial results on June 4, 2025, alongside a conference call to discuss the fourth quarter 2024 earnings released on May 28, 2025 [1] Group 1: Company Overview - Xcel Brands, Inc. is a media and consumer products company involved in the design, licensing, marketing, live streaming, and social commerce sales of various branded products [3] - The company was founded in 2011 with a vision to innovate shopping, entertainment, and social media through social commerce [3] - Xcel owns several brands including Halston, Judith Ripka, and C. Wonder, and has collaborations with brands like TowerHill by Christie Brinkley and LB70 by Lloyd Boston [3] Group 2: Business Strategy and Performance - Xcel Brands employs a modern consumer products sales strategy that includes interactive television, digital live-stream shopping, social commerce, and e-commerce channels [3] - The company's brands have generated over $5 billion in retail sales through livestreaming and digital channels, with more than 20,000 hours of content production in live-stream and social commerce [3] - Xcel's brand portfolio reaches over 40 million social media followers and has a broadcast reach into 200 million households [3] Group 3: Leadership and Expertise - The executive team at Xcel Brands possesses significant experience in live streaming, production, merchandising, design, marketing, retailing, and licensing [3] - The team has a proven track record of success in enhancing branded consumer products companies [3]

Core Insights - AnaptysBio's investigational drug rosnilimab shows a best-in-disease profile for treating moderate-to-severe rheumatoid arthritis (RA), demonstrating JAK-like efficacy and durable responses [1][2][3] Efficacy and Clinical Outcomes - In a Phase 2b trial with 424 patients, rosnilimab achieved significant clinical improvements, including low disease activity (LDA) and remission on the Clinical Disease Activity Index (CDAI) [1][2][3] - By Week 12, 45% of patients achieved CDAI LDA, increasing to 69% by Week 14, indicating a strong response to treatment [3][4] - Rosnilimab demonstrated a rapid onset of ACR20 response, comparable to upadacitinib, with a substantial decrease in C-reactive protein (CRP) levels [2][3] Safety and Tolerability - Rosnilimab exhibited a favorable safety profile, with no treatment-related serious adverse events (SAEs) reported and a low incidence of injection site reactions [10][11] - Less than 2% of patients discontinued treatment due to adverse events, indicating good tolerability [10][11] Market Potential - The findings suggest rosnilimab could capture a significant share of the ~$20 billion U.S. RA market, with potential for extended dosing intervals [2][3] - The company aims to complete ongoing studies for rosnilimab in ulcerative colitis, with initial data expected in Q4 2025 [2][14] Mechanism of Action - Rosnilimab targets PD-1+ T cells, aiming to restore immune homeostasis and reduce inflammation associated with RA [19][21] - The drug demonstrated a ~90% reduction in PD-1 T cells and a ~50% reduction in PD-1+ T cells, indicating robust pharmacological activity [8][19] Future Developments - AnaptysBio plans to advance rosnilimab's clinical development and explore its application in other autoimmune diseases [21][22] - The company is committed to developing innovative treatments that address the long-term needs of patients with chronic inflammatory conditions [21][22]

MONACO, June 03, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company’s 2024 Sustainability Report is available for download and can be accessed from its website using the link provided below. The 2024 Sustainability Report has been prepared in accordance with the Global Reporting Initiative (GRI) Sustainability Reporting Guidelines, 'in accordance with the GRI Standards', and the Sustain ...

Group 1 - Nasdaq reported its monthly trading volumes for May 2025 on its Investor Relations website [1] - Nasdaq is a leading global technology company that serves various financial market participants, including corporate clients, investment managers, banks, brokers, and exchange operators [2] - The company aims to enhance liquidity, transparency, and integrity in the global economy through its diverse offerings of data, analytics, software, and exchange capabilities [2] Group 2 - Nasdaq provides a range of client-centric services that enable clients to optimize and execute their business vision with confidence [2] - The company has a commitment to delivering world-leading platforms that facilitate interaction with global capital markets [2]

SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (“Presidio” or the “Company”) (NASDAQ: SQFT; SQFTP; SQFTW), an internally managed, diversified real estate investment trust (“REIT”), today announced that it has received formal notice from Nasdaq stating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Company's common stock will continue to be listed and traded on Nasdaq.. To regain compliance with the ...

Windtree intends to accept cryptocurrency as an option for payment and also to hold as an assetWARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies for critical conditions and diseases, announced that its Board of Directors has agreed that the Company will create a cryptocurrency policy that will allow the C ...

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at the 1st Annual D.A. Davidson Technology & Consumer Conference on Tuesday, June 10, 2025, at 2:40 PM C.T. A webcast of the presentation will be available on the company’s investor relations website at http://investors.spscommerce.com/events.cfm. About SPS Commerce SPS Commerce is the world’s leading retail network, connecting trading ...

Fort Lauderdale, FL, June 03, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company, today announced that its subsidiary, SMCB Solutions Private Limited (“SemiCab India”), has recently signed four new pilot agreements and four contract expansions with eight enterprise-scale customers in India. Under the new and expanded contracts, SemiCab India will provide enterprise-level shipping services through its AI-powered, ...